Direct supply from JIMPOCHEM featuring certified quality control, high purity, and complete batch traceability.
A Comprehensive Industry White Paper on Purchasing Azelaic Acid and Metronidazole from Qualified Manufacturing Sources
In modern dermatological therapeutics and pharmaceutical formulation engineering, the strategic sourcing of high-purity Active Pharmaceutical Ingredients (APIs) forms the cornerstone of product efficacy, clinical safety, and global market compliance. Among the most widely requested active ingredients for inflammatory skin disorders—specifically Rosacea (erythematotelangiectatic and papulopustular subtypes), Acne Vulgaris, and post-inflammatory hyperpigmentation—Azelaic Acid (CAS 123-99-9) and Metronidazole (CAS 443-48-1) represent gold-standard therapeutic agents.
When chemical procurement teams, contract development and manufacturing organizations (CDMOs), and pharmaceutical brand managers seek to Buy Azelaic Acid And Metronidazole, evaluating chemical manufacturers demands a holistic assessment extending far beyond basic pricing. Procurement strategies must prioritize regulatory compliance (FDA DMF, CEP/COS, EU REACH), physical particle size optimization (micronization for enhanced skin permeability), batch-to-batch analytical purity (via validated HPLC and GC-MS protocols), and total supply chain security.
While Azelaic Acid functions via competitive inhibition of tyrosinase, normalization of follicular keratinization, and reduction of 5-alpha-reductase activity, Metronidazole exerts powerful antiprotozoal and antibacterial anti-inflammatory responses by scavenging reactive oxygen species (ROS). Sourcing both APIs simultaneously from a centralized, vertically integrated Chinese chemical manufacturer allows formulation laboratories to streamline raw material validation, reduce analytical testing redundancies, and guarantee identical regulatory compliance standards across complex topical emulsion lines.
Technical performance metrics for industrial formulation, comparative solubility, and pharmacopeial standards.
Chemical Structure: HOOC-(CH2)7-COOH (Saturated Dicarboxylic Acid)
Molecular Weight: 188.22 g/mol
Key Functional Properties:
Chemical Structure: 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethanol
Molecular Weight: 171.15 g/mol
Key Functional Properties:
| Analytical Parameter | Azelaic Acid (Pharmaceutical Grade) | Metronidazole (USP / EP Grade) |
|---|---|---|
| Appearance | White to off-white crystalline powder | White or pale-yellow crystalline powder |
| Assay (HPLC / Titration) | 99.0% – 101.0% (Dry Basis) | 99.0% – 101.0% (Anhydrous Basis) |
| Melting Point | 106°C to 110°C | 159°C to 163°C |
| Loss on Drying | ≤ 0.5% | ≤ 0.5% |
| Residue on Ignition | ≤ 0.1% | ≤ 0.1% |
| Heavy Metals (as Pb) | ≤ 10 ppm | ≤ 10 ppm |
| Particle Size Distribution | Customizable: Standard (80 mesh) / Micronized (D90 < 10 μm) | Micro-milled options available upon buyer request |
Why procurement officers from international pharmaceutical giants partner with JIMPOCHEM for bulk chemical manufacturing.
Situated in the Chemical Industry Park of Jinan City, Shandong Province, JIMPOCHEM benefits from immediate access to core petrochemical and oleochemical feedstocks. Oleic acid oxidation pathways for Azelaic Acid production are optimized onsite, minimizing raw material volatility and protecting buyers from price spikes.
Our expansive industrial complex leverages automated closed-loop synthesis reactors, continuous crystallization technology, and automated centrifuge drying systems. This digital infrastructure ensures superior batch-to-batch consistency and scalable annual output exceeding thousands of metric tons.
In full compliance with China’s national "Dual-Carbon" sustainability targets, JIMPOCHEM operates state-of-the-art MVR wastewater evaporation systems and regenerative thermal oxidizer (RTO) waste-gas treatments, eliminating supply chain interruption risks due to environmental audits.
Serving over 5,000 international chemical and pharmaceutical companies across 200+ countries, JIMPOCHEM operates as a designated chemical service provider. We provide customized synthesis, flexible batch sizes ranging from pilot-scale R&D quantities to multi-ton containerized maritime shipments, and full documentation suites (CoA, SDS, Technical Data Sheets, Regulatory Master Files).
Empowering seamless market entry across North American, European, Latin American, and Asia-Pacific regulatory regimes.
Securing regulatory authorization for topical drug products and cosmetic treatments requires transparent raw material origin data. JIMPOCHEM backs every batch of Azelaic Acid and Metronidazole with comprehensive analytical dossiers including:
Navigating cross-border customs regulations, hazardous chemical handling compliance (DG vs Non-DG declarations), and local storage requirements can present significant logistical friction. Our dedicated international trade team provides:
Market forecasts, novel vehicle technologies, and emerging combination dermatological therapies.
To reduce cutaneous irritation associated with high-concentration Azelaic Acid (15%-20%) and preserve Metronidazole stability against photo-degradation, modern formulators utilize liposomal and polymeric microencapsulation. JIMPOCHEM offers ultra-fine particle sizes ideal for encapsulation processing.
Clinical dermatological research increasingly validates multi-target therapies. Combining Azelaic Acid's anti-keratinizing actions with Metronidazole's anti-Demodex mechanisms provides accelerated resolution of papulopustular rosacea lesions compared to monotherapy approaches.
Lower-concentration Azelaic Acid (up to 10%) has exploded across global Over-The-Counter (OTC) skincare markets for redness reduction and hyperpigmentation control. Sourcing raw materials from direct factory suppliers allows brands to optimize cost-goods-sold (COGS) at scale.
Practical deployment of Azelaic Acid and Metronidazole across prescription, OTC, and clinical settings.
For ethical pharmaceutical manufacturing, Azelaic Acid (15-20% w/w) and Metronidazole (0.75-1.0% w/w) serve as active ingredients in prescription topical gels, creams, and lotions. Key vehicle parameters require optimal solubilization agents (such as Ethoxydiglycol or Polyethylene Glycols) and precise pH control (typically pH 4.5 – 5.5) to maintain chemical stability and maximize epidermal bioavailability.
In global cosmetic markets, high-purity Azelaic Acid is formulated into brightener serums, target spot correctors, and redness-relief emulsions. When paired with soothing excipients such as Squalane, Tranexamic Acid, or Sodium Hyaluronate, formulators achieve rapid anti-inflammatory efficacy while eliminating stinging sensation for sensitive epidermal barrier profiles.
16 Years of Excellence in High-End Fine Chemicals and Cosmetic Raw Material Manufacturing
JIMPOCHEM CO., LTD was established in 2010 and is headquartered in the Chemical Industry Park of Jinan City, Shandong Province. The company covers an area of over 500 acres and is a professional chemical raw material manufacturer that integrates research and development, production, sales, and technical services. Its core focus is on high-end fine chemicals and cosmetic raw materials.
We have obtained multiple product-related certifications, including ISO quality system certification and environmental management system certification, and are committed to providing high-quality chemical products and one-stop procurement service solutions to global customers. Our core team comprises experts with over 10 years of experience in the chemical industry, offering customized solutions in product development, formula optimization, and supply chain management.
Explore our complete product catalog spanning Daily Chemical Ingredients, Organic Synthetics, Fluorine Compounds, and Healthcare Raw Materials.
Addressing key technical, regulatory, procurement, and formulation queries regarding Azelaic Acid & Metronidazole supply.
Explore related fine chemicals, pharmaceutical excipients, and industrial actives direct from manufacturer stock.
JIMPOCHEM
